Elizabeth Floyd, Ph.D.

John S. McIlhenny Endowed Postdoctoral Fellowship
Associate Professor


(225) 763-2724
(225) 763-0273
Send E-mail 


Ph.D., Louisiana State University, Baton Rouge, LA, 1997, Biochemistry
B.S.N., University of Alabama at Birmingham, Birmingham, AL, 1977, Nursing


Dr. Floyd has a general interest in protein turnover mediated by the ubiquitin-proteasome system. In particular, her laboratory is interested in understanding how the ubiquitin-proteasome pathway affects adipose tissue biology. Research in the laboratory is currently focused on how ubiquitin and ubiquitin-like modifications regulate the activity of the peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear hormone receptor required for the formation and maintenance of adipocytes. Our studies show that the ubiquitin ligase Siah2 selectively regulates PPARgamma activity in adipose tissue while also acting to control obesity-related adipose tissue inflammation, the balance between adipose tissue expansion via hyperplasia or hypertrophy and the link between adipocyte hypertrophy and obesity-induced insulin resistance.

Another area of interest in the laboratory is the impact of botanical supplementation on insulin sensitivity. These studies explore the effects of extracts from Russian Tarragon and Bitter Melon, plants with a long history of ameliorating the symptoms of type 2 diabetes. The studies currently focus on identifying the bioactive components of the botanical extracts that enhance insulin signaling in skeletal muscle and improve glucose metabolism.


Fuller SE, Yu Y, Mendoza TM, Ribnicky DM, Cefalu WT, Floyd ZE. Potential adverse effects of botanical supplementation in high fat-fed female mice. BMC Biology of Sex Differences. 2018; Sept 12;9 (1):41. PMCID: PMC30208938

Yu Y, Mendoza TM, Ribnicky DM, Noland RC, Mynatt RL, Raskin I, Cefalu WT, Floyd ZE. An extract of Artemisia dracunculus L prevents obesity-related skeletal muscle and hepatic lipid accumulation. Molecular Nutrition and Food Research. 2018; April; 62 (8): e1700856. PMCID PMC5929974

Kilroy G, Dietrich M, Wu X, Gimble JM, Floyd ZE. Isolation of Murine Adipose-derived Stem Cells. Methods in Molecular Biology, 2018; Vol 1773: 137-146.

Xu B, Allard C, Alvarez-Mercado AI, Kim JH, Hewitt SC, Urano R, Korach KS, Levin ER, Arvan P, Floyd, ZE, Mauvais-Jarvis F. Estrogens promote misfolded proinsulin degradation to protect insulin production and delay diabetes. 2018; Cell Reports. July 3; 24:181-196. PMCID: PMC6092934

Kilroy G, Burk DH, Floyd, ZE. Siah2 mediates early events in commitment to an adipogenic pathway. Journal of Biological Chemistry. 2016; Dec 30; 291(53): 27289-27297. PMCID PMC5207155

Kilroy G, Carter LE, Newman S, Burk DH, Manuel J, Moller A, Bowtell DD, Mynatt RL, Ghosh S, Floyd ZE. The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation. Obesity 2015; 23: 2223-2232. PMCID: PMC4633373

Kilroy SG, Kirk-Ballard H, Carter LE, Floyd ZE. The ubiquitin ligase Siah2 regulates PPARgamma activity in adipocytes. Endocrinology 2012; 153 (3): 1206-1218. PMCID: PMC3281538.

Floyd ZE and Stephens JM. Controlling a master switch of adipocyte development and insulin sensitivity: Covalent modification of PPARgamma. Biochem Biophys Acta 2012; 1822: 1090-1095. PMCID: PMC3355475

Kilroy SG, Burk DH, Floyd ZE. High efficiency siRNA transfection of adipocytes using “reverse transfection”. PLoS One 2009; 4(9) e6940. PMCID: PMC2736387

Kilroy SG, Zhang X, Floyd ZE. PPARgamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal. Obesity 2009; (4): 665-73. PMCID: PMC2585986

Floyd ZE, Stephens JM. Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation. Obes Res. 2004; Jun;12(6):921-8.
^ top